Results 101 to 110 of about 5,934 (217)

Psychedelics as a potential treatment for tobacco use disorder: a systematic review

Discover Mental Health
Introduction Despite considerable efforts, tobacco use disorder persists as a significant public health issue. The effectiveness of current smoking cessation therapies is limited, leading to a growing interest in alternative treatment approaches such as ...
S. K. Spoelstra, R. A. Schoevers, S. D. Venema, H. Knegtering   +3 more
doaj   +1 more source

Treatment of neuropathic pain with repeated low-dose MDMA: a case report

Frontiers in Psychiatry
A 64-year-old male patient who suffered from traumatic life experiences and neuropathic pain after oncological chemotherapy was treated with medium to high doses of lysergic acid diethylamide (LSD) and high doses and microdoses of ...
Peter Gasser, Matthias E. Liechti, Friederike Holze   +2 more
doaj   +1 more source

Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD).

, 1996
OBJECTIVE: To identify a distinctive chronic visual complication of lysergic acid diethylamide (LSD) use. DESIGN: Description of the clinical findings in three patients with this disorder. SETTING: A neuro-ophthalmology referral center.
Purvin, V., Kawasaki, A.
core  

The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules

Cell Reports
Summary: Increasing global concerns about psychoactive substance addiction and psychotic disorders highlight the need for comprehensive research into the structure-function relationship governing ligand recognition between these substances and their ...
Kexin Jiang, You Zheng, Liting Zeng, Ling Wang, Fei Li, Jun Pu, Yingli Lu, Suwen Zhao, Fei Xu   +8 more
doaj   +1 more source

Club drugs: Um Novo Perfil de Abuso de Substâncias em Adolescentes e Jovens Adultos.

Acta Médica Portuguesa, 2011
Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; Gamma-hydroxybutyrate (GHB) and Flunitrazepam.
Diogo Frasquilho Guerreiro, Ana Lisa Carmo, Joaquim Alves da Silva, Rita Navarro, Carlos Góis   +4 more
doaj   +1 more source

A Need for Legal Reclassification: Therapeutic and Medical Benefits Using Lysergic Acid Diethylamide

, 2021
Depression, addiction, and other mental health disorders present a serious challenge socially, personally, and economically, creating an urgent need for novel treatments.
McDowell, Cynthia
core  

Therapeutic Use of Lysergic Acid Diethylamide and Psilocybin [PDF]

openLa tesi ha come scopo quello di fare una panoramica sul possibile utilizzo in ambito terapeutico della dietilamide dell'acido lisergico e della psilocibina.
ROSELLI, PIETRO
core  

125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells

, 1985
125I-Lysergic acid diethylamide (125I-LSD) binds with high affinity to serotonergic sites on rat choroid plexus. These sites were localized to choroid plexus epithelial cells by use of a novel high resolution stripping film technique for light ...
PR Hartig, KA Yagaloff
core   +1 more source

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).

, 2016
1-Propionyl-d-lysergic acid diethylamide hemitartrate (1P-LSD) has become available as a 'research chemical' in the form of blotters and powdered material.
Folker Westphal, Alexander Stratford, Simon D. Brandt, Kavanagh, PV, Simon P. Elliott, Halberstadt, AL, Elliott, SP, Jason Wallach, Hoang, K, Stratford, A, Brandt, SD, Westphal, F, Wallach, J, Khoa Hoang, Adam L. Halberstadt, Pierce V. Kavanagh   +15 more
core   +1 more source

Lysergic Acid Diethylamide (LSD): a report on its effects and psychotherapeutic use

, 1965
Lysergic acid diethylamide, LSD, was accidentally discovered by Dr. Albert Hofmann in 1943 while he was working as a research chemist for Sandoz Laboratories.
Abell, John Minor
core